Gadobutrol Injection
Product Images NDC 70436-217

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gadobutrol (NDC 70436-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

70436-216-36 (Image 02)

This is a description of Gadobutrol Injection, a sterile solution for intravenous use only. The medication is contained in a multiple-dose container, with a usual dosage specified in the package insert. It should be stored at a temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The text also mentions that unused portions should be discarded within 24 hours after initial use. The manufacturing details indicate that it is produced by Hainan Poly Pharm. Co. Ltd, China, and distributed by SS Run Pharmaceutical, LLC, Ohio. The National Drug Code (NDC) for this product is 70436-216-36.*

FDA Label Image

70436-217-38 (Image 04)

This is a description of Gadobutrol Injection in a Pharmacy Bulk Package for intravenous use only. It is a sterile solution with a dose of 0.1 mL/kg. The package should be discarded within 24 hours after initial puncture. The storage temperature should be between 20°C to 25°C. The product is distributed by Slate Run Pharmaceuticals, LLC. Multiple doses are available in the container. It is recommended to refer to the package insert for usual dosage information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.